Co-Authors
This is a "connection" page, showing publications co-authored by AJAY SHESHADRI and SAADIA FAIZ.
Connection Strength
4.260
-
Pulmonary Function Testing in Patients with Tracheostomies: Feasibility and Technical Considerations. Lung. 2021 06; 199(3):307-310.
Score: 0.770
-
Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection. Transpl Infect Dis. 2019 Aug; 21(4):e13105.
Score: 0.678
-
Updates in Drug-Related Pneumonitis Due to Targeted Oncologic Therapies. J Immunother Precis Oncol. 2024 Nov; 7(4):272-282.
Score: 0.247
-
Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis. Clin Lung Cancer. 2024 Nov; 25(7):624-633.e2.
Score: 0.243
-
The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Cancer. Front Oncol. 2023; 13:1295267.
Score: 0.232
-
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. Oncologist. 2023 Nov 02; 28(11):e1065-e1074.
Score: 0.231
-
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept. Front Immunol. 2023; 14:1249511.
Score: 0.229
-
Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study. Cancer Med. 2023 09; 12(17):17753-17765.
Score: 0.227
-
Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature. J Immunother Precis Oncol. 2023 May; 6(2):111-116.
Score: 0.221
-
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study. Cancer. 2022 07 15; 128(14):2736-2745.
Score: 0.207
-
Cavitary Lesions in a Hematopoietic Stem Cell Transplant Patient. Arch Bronconeumol. 2021 12; 57(12):768.
Score: 0.202
-
Role of Infliximab in Immune Checkpoint Inhibitor-Induced Pneumonitis. J Immunother Precis Oncol. 2020 Nov; 3(4):172-174.
Score: 0.187
-
Cavitary Lesions in a Hematopoietic Stem Cell Transplant Patient. Arch Bronconeumol (Engl Ed). 2020 Jun 20.
Score: 0.183
-
Diaphragmatic Myopathy Associated with Dual Immune Checkpoint Inhibitors in a Patient with Renal Cell Carcinoma. J Immunother Precis Oncol. 2024 Nov; 7(4):304-307.
Score: 0.062
-
Gravity- vs?Wall Suction-Driven Large-Volume Thoracentesis: A Randomized Controlled Study. Chest. 2024 Dec; 166(6):1573-1582.
Score: 0.061
-
Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With Cancer. J Infect Dis. 2023 11 28; 228(11):1549-1558.
Score: 0.058
-
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications. Front Immunol. 2020; 11:590494.
Score: 0.048
-
Complications following symptom-limited thoracentesis using suction. Eur Respir J. 2020 11; 56(5).
Score: 0.047
-
Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal: An Exploratory Study. J Bronchology Interv Pulmonol. 2020 Jan; 27(1):4-13.
Score: 0.044
-
Routine Microbiologic Studies of Pleural Fluid Specimens in Cancer Patients. Am J Med. 2020 02; 133(2):240-244.
Score: 0.043
-
Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis. 2018 Dec; 20(6):e12994.
Score: 0.040